| Angeltalk, Inc. | |
|
1302 Timberland Dr, Van Buren, AR 72956-9053 | |
| (479) 414-6616 | |
| (479) 474-5543 |
| Full Name | Angeltalk, Inc. |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 1302 Timberland Dr, Van Buren, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487771499 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angeltalk, Inc. 1302 Timberland Dr, Van Buren, AR 72956-9053 Ph: (479) 414-6616 | Angeltalk, Inc. 1302 Timberland Dr, Van Buren, AR 72956-9053 Ph: (479) 414-6616 |
News Archive
The U.S. Food and Drug Administration has approved two drugs, pentetate calcium trisodium injection (Ca-DTPA) and pentetate zinc trisodium injection (Zn-DTPA) for treating certain kinds of radiation contamination. The FDA is approving these two drugs as part of its ongoing effort to provide the American public the best available protection against nuclear accidents and terrorist threats.
One in every eight Americans is aged 65 years or older and, by 2030, it is expected to be one in five. As the number of older Americans increases, healthcare providers and researchers must understand and address the needs of this growing population.
Cell Therapeutics, Inc. announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals.
Researchers report they can generate human motor neurons from stem cells much more quickly and efficiently than previous methods allowed. The finding, described in Nature Communications, will aid efforts to model human motor neuron development, and to understand and treat spinal cord injuries and motor neuron diseases such as amyotrophic lateral sclerosis (ALS).
› Verified 2 days ago
Mary Beth Morris, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1807 Bunker Hill Dr, Van Buren, AR 72956 Phone: 479-471-9598 | |
Mrs. Emily Nicole Hurst, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 816 Fayetteville Rd, Van Buren, AR 72956 Phone: 268-294-9479 | |
Brooks Speech Language Therapy Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1117 Tapp Rd, Van Buren, AR 72956 Phone: 321-501-0282 | |
Abigail Abrey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 816 Fayetteville Rd, Van Buren, AR 72956 Phone: 479-268-2949 | |
Ms. Pamela D. Morrison, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1120 Solitude Dr, Van Buren, AR 72956 Phone: 479-883-4010 Fax: 479-474-3105 | |
Mary Audrah Reynolds, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2221 E Pointer Trl, Van Buren, AR 72956 Phone: 479-474-7942 | |
Denise Paxton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 Solitude Dr, Van Buren, AR 72956 Phone: 479-414-0090 |